Harding and colleagues tested various EZH2 inhibitors (EPZ-6438, GSK126 and UNC1999) and found that a subset of MM cell lines were sensitive to single agent EZH2 inhibition, whereas others were resistant [37]. Here, EZH2 is linked to Miyoshi myopathy.